ESC 365 - Doctor Abbasin Zegard

Speaker illustration

Doctor Abbasin Zegard

Aston University, Birmingham (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Heart Rythm Association

Presentations Articles

Intra-operative ultra high-frequency ECG in relation to left ventricular reverse remodelling after cardiac resynchronization therapy

Event: EHRA 2024

Topic: Electrocardiography (ECG)

Session: Poster session on ventricular tachycardia, others

Arrhythmic risk stratification in non-ischemic cardiomyopathy using cardiovascular magnetic resonance

Event: EHRA 2024

Topic: Clinical

Session: Arrhythmias 10

Left ventricular ejection fraction and myocardial fibrosis in survivors of ventricular fibrillation and ventricular tachycardia

Event: EHRA 2024

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Poster session on devices, others

Cardiac resynchronization therapy using endocardial versus trans-coronary sinus, epicardial left ventricular pacing: the Epi-Endo study

Event: EHRA 2024

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Poster session on devices, others

Myocardial fibrosis predicts ventricular arrhythmias and sudden death after cardiac electronic device implantation

Event: EHRA 2022

Topic: Device Treatment

Session: Young Investigator Award - Clinical

Gray zone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction greater than 35%

Event: EHRA 2021

Topic: Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Session: Cardiac arrest in Europe

Myocardial fibrosis as a predictor of sudden death in patients with coronary artery disease

Event: EHRA 2021

Topic: Diagnostic Methods

Session: New insights in ventricular arrhythmias I

Grayzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction greater than 35%

Event: EHRA 2021

Topic: Device Treatment

Session: Oral abstract session - Atrial fibrillation and arrhythmias

Myocardial phenotype of patients with indications for secondary prevention implantable cardioverter defibrillator therapy: insights from cardiovascular magnetic resonance

Event: EHRA 2019

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Antibradycardia Pacing

Long-term outcomes of cardiac resynchronization therapy in adult congenital heart disease

Event: EHRA 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac Resynchronization Therapy

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources